Skip to content

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Sign In Start 14-Day Free Trial

Home›Companies›Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc.

DFTX

Held by 7 specialist biotech funds

High Convergence

7 funds opened new positions. Short interest: 9.8% of float.

Share

Score Holdings Short Interest Catalysts Insiders Research

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

DFTX: Held by 7 Biotech Hedge Funds (2026) | BiotechEdge

Signal Score

5.5/10

7 funds opened new positions●●

No recent insider activity●●

No upcoming catalysts●●

Held by 7 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

7 fund convergence

Driehaus CapitalNew

RTW InvestmentsNew

Avoro Capital AdvisorsNew

Commodore CapitalNew

OrbiMed AdvisorsNew

Deep Track CapitalNew

Eventide Asset ManagementNew

AI Signal

RTW initiates $5.7M position in DFTX, bringing specialist fund count to 7. Convergence among RTW, OrbiMed, Deep Track, Avoro, Driehaus, Commodore, and Eventide — all funds with deep clinical-stage diligence infrastructure — represents a high-conviction cluster signal that warrants close attention to upcoming catalysts. Verify current cash runway against anticipated data readouts, as any runway below 4 quarters would elevate dilution risk materially given DFTX's likely pre-revenue stage.

Unlock full AI analysis — 14-day free trial

Short Interest

Short Shares

10.64M

Change

+15.0%

Days to Cover

5.0

% of Float

9.8%

Settlement

Jun 15, 2026

Short interest over 7 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13G/ADeep Track Capital3.0%May 15, 2026

Position Details

Driehaus CapitalNEW POSITIONMay 15, 2026

Start free trialfor share counts, dollar values & AI analysis

6 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Also Held by These Funds

AVTX1 fund ELVN1 fund CRVS1 fund EYPT1 fund STTK1 fund SVA1 fund AAVXF1 fund ADCT1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: